Breast cancer is still the most common cancer among Singaporean women, affecting over 1000 women annually. Its rising incidence makes the disease a major public health problem. Fortunately, it is encouraging to know that the survival of patients with breast cancer in Singapore is improving. This is all due to increase in screening detecting early disease, and better acceptance of treatment of the disease.

At the National Cancer Centre (S), we continue to be committed in providing our patients with prompt optimal care under a multidisciplinary team. We aim to provide patients with not only cost effective gold standards of care, but also make cutting edge medicine available.

With an increasing pool of cancer survivors, it is important for us to be mindful of other non-cancer issues that result from or are associated with breast cancer treatment. Newer research has allowed physicians to decrease morbidity without compromising quality and mortality in the treatment of breast cancer. In this issue, we hope to highlight some of these topics and to update our fellow colleagues in the community.

Happy reading.

See Hui Ti
Editor